Menu
PURPOSE
ISNI aims to promote the next generation of neuroimmunologists, and acknowledges that the mid-career stage (Assistant or Associate Professors, between 10 and 20 years of initial Assistant Professor appointment) presents particular challenges. The “We Are Neuroimmunology” awards aims to recognize the emerging contribution of two internationally competitive applicants of the highest calibre in the two main research streams; clinical neuroimmunology and fundamental neuroimmunology.
AWARD
The two successful applicants will be invited to present their research at the ISNI conference, and they, their research and team will be featured in social media and all communication channels of ISNI to the global neuroimmunology community. Budget permitting, a sum of ~$2,500 will be awarded for each award.
CRITERIA FOR SUCCESSFUL APPLICATIONS
Successful candidates should make a case of why they and their research program and discoveries exemplify the tag line “We Are Neuroimmunology”. Evidence of a rising trajectory, contribution to the field and mentorship of the next generation would be considered must-haves. Leadership in publications and taking on leadership roles are also essential and should be emphasized.
PROPOSED APPLICATION TIMELINE:
APPLICATION PEER-REVIEW
ISNI Executive: Professor Roberto Furlan (President: abjucator), Professor Heinz Wiendl (vice-president), Professor Lesley Probert (Secretary). Members of the International Advisory Board. Professor Fabienne Brilot (IAB), two Members of the International Advisory Board, and one senior member of ISNI meeting Local Organizing Committee with endorsement by ISNI executive. Secretariat provided by EEM. International Advisory Board members may be invited to peer-review depending on number of applications received.
APPLICANT ELIGIBILITY:
APPLICATION:
Application outcomes will be announced in early September 2025.
Two categories are available: clinical research and fundamental research. Applicants must select the category in which they wish to apply.
Applicants must declare the number of years post-PhD and/or years post initial Assistant Professor appointment.
A. Career context – briefly explain your circumstances taking into account any clinical and/or academic loading and/or personal circumstances (max 250 words). Career disruption are detailed in Section F.
B. Summarize why you and your research program exemplify the statement “We are Neuroimmunology” (100 words).
C. Nominate your five best publications from the past 10 years using the following format and starting by the newest publication: all authors (first and last names), title, full journal name, issues, pages, year of publication Mention any co-authorship using *.
C1. Provide explanations of why these publications have been selected, outlining the contribution of the applicant, the quality of the publications selected and their contribution to science and their innovation, use Google scholar citations, and FWIC) (max 250 words).
D. Provide a brief explanation on the research impact of your discover(ies) (max 250 words). Research impact can include knowledge gain or/and translation. It should be based on verifiable evidence (detailed in D1), and not on the potential or future capacity of the discovery.
D1. Provide verifiable evidence. (max 100 words).
E. Provide a brief explanation of your research leadership and contribution to Neuroimmunology (professional, institutional, and team) (max 250 words).
F. Provide a brief explanation of your mentorship leadership and your contribution to the training of the next generation of neuroimmunologists (max 250 words). It should be based on verifiable evidence (primary versus secondary supervision, completion of higher degree by research, i.e. PhD and MPhil, etc..)
G. Career disruption (max 100 words).
APPLICATION SCORING MATRIX (score relative to opportunity and career disruption).
|
Applications Sections |
Criteria |
Weighti ng |
Score 1 to 5 (1: not competitive, 5: competitive) |
|
B |
Case for We are Neuroimmunology |
5% |
1-2-3-4-5 |
|
C |
Publications (also includes innovation and applicant contribution to the publications) |
25% |
1-2-3-4-5 |
|
D |
Reach and significance of the research impact (Knowledge gain/translation) |
25% |
1-2-3-4-5 |
|
E |
Research Leadership |
25% |
1-2-3-4-5 |
|
F |
Mentorship Leadership |
20% |
1-2-3-4-5 |
Committee member COI will be disclosed before application scoring.
MISSON STATEMENT
Neuroimmunology is a rapidly expanding field with tremendous and daily advances in fundamental and clinical research, both able to significantly impact patient care and clinical practise. Since 1982, ISNI has been the principal society of neuroimmunology.
At ISNI France 2021, ISNI will formally launch the “We are Neuroimmunology” campaign. The campaign is designed to recognize the contribution of the multifaceted Neuroimmunology community and affirm ISNI’s leadership in the field.
Our first event is the “We are Neuroimmunology Mid-Career Awards”. Their aim is to promote the next generation of neuroimmunologists, and acknowledge that the mid-career stage (between >10 and >20 years post PhD, associate professor and assistant professor levels) presents challenges. The “We are Neuroimmunology Mid-Career” awards aim to recognize the emerging contribution of two internationally competitive applicants of the highest calibre in the two main research streams; clinical neuroimmunology and fundamental neuroimmunology.
C.F. 97644730588 | Managed by EEM Services